Home » Stocks » UG

United-Guardian, Inc. (UG)

Stock Price: $15.28 USD 0.00 (0.00%)
Updated November 27, 4:00 PM EST - Market open
Pre-market: $15.00 -0.28 (-1.83%) Nov 30, 9:29 AM

Stock Price Chart

Key Info

Market Cap 70.20M
Revenue (ttm) 12.44M
Net Income (ttm) 4.08M
Shares Out 4.59M
EPS (ttm) 0.89
PE Ratio 17.17
Forward PE n/a
Dividend $0.78
Dividend Yield 5.10%

Stock Quote

Trading Day November 27
Last Price $15.28
Previous Close $15.28
Change ($) 0.00
Change (%) 0.00%
Day's Open 14.90
Day's Range 14.54 - 15.01
Day's Volume 7,572
52-Week Range 11.43 - 19.84

More Stats

Market Cap 70.20M
Enterprise Value 61.17M
Earnings Date (est) n/a
Ex-Dividend Date Nov 30, 2020
Shares Outstanding 4.59M
Float n/a
EPS (basic) 0.90
EPS (diluted) 0.89
FCF / Share 0.81
Dividend $0.78
Dividend Yield 5.10%
Earnings Yield 5.82%
FCF Yield 5.32%
Payout Ratio 107.80%
Shares Short 718
Short Ratio 0.14
Short % of Float n/a
Beta -0.01
PE Ratio 17.17
Forward PE n/a
P/FCF Ratio 18.79
PS Ratio 5.65
PB Ratio 6.19
Revenue 12.44M
Operating Income 4.78M
Net Income 4.08M
Free Cash Flow 3.74M
Net Cash 9.03M
Net Cash / Share 1.96
Gross Margin 63.86%
Operating Margin 38.44%
Profit Margin 32.80%
FCF Margin 30.04%
ROA 22.65%
ROE 35.26%
ROIC 51.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue13.6013.4512.9710.7814.0113.4515.4213.8314.3413.72
Revenue Growth1.14%3.68%20.33%-23.06%4.14%-12.76%11.51%-3.58%4.48%-
Gross Profit7.948.107.675.898.808.139.818.618.698.47
Operating Income5.405.585.243.396.295.497.306.106.145.06
Net Income4.764.353.842.584.614.055.904.834.723.80
Shares Outstanding4.594.594.594.594.594.604.604.604.604.74
Earnings Per Share1.040.950.840.561.000.881.281.051.030.80
EPS Growth9.47%13.1%50%-44%13.64%-31.25%21.9%1.94%28.75%-
Dividend Per Share1.101.051.420.751.000.800.971.360.800.63
Dividend Growth4.76%-26.06%89.33%-25%25%-17.53%-28.68%70%26.98%-
Operating Cash Flow4.484.953.992.295.204.485.815.384.444.09
Capital Expenditures-0.11-0.07-0.04-0.17-0.06-0.05-0.29-0.25-0.27-0.45
Free Cash Flow4.364.883.952.125.144.435.525.134.163.64
Cash & Equivalents7.928.178.4510.6411.8011.4110.509.4910.399.83
Net Cash / Debt7.928.178.4510.6411.8011.4110.509.4910.399.83
Assets12.3612.5412.8514.8715.6915.9415.6513.8615.2614.07
Liabilities1.731.621.461.051.111.201.411.021.141.03
Book Value10.6310.9211.4013.8214.5814.7414.2412.8414.1113.05
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name United-Guardian, Inc.
Country United States
Employees 23
CEO Kenneth H. Globus

Stock Information

Ticker Symbol UG
Stock Exchange NASDAQ
Sector Consumer Defensive
Industry Household & Personal Products
Unique Identifier NASDAQ: UG

Description

United-Guardian manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL PF and NORGEL, a preservative-free form of LUBRAJEL; LUBRAJEL NATURAL, which are natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; LUBRASLIDE and B-122 powdered lubricants that are used in the manufacture of pressed powders, eyeliners, and rouges; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. The company's medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company's industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based cleanser. It also conducts research and development, primarily related to the development of cosmetic ingredients. The company markets its products through marketing partners, distributors, and wholesalers. United-Guardian, Inc. was founded in 1942 and is headquartered in Hauppauge, New York.